Thomas Häuser

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Rachel Jones, Jan Willem Cohen Tervaert, Thomas Häuser et al. · New England Journal of Medicine · 2010 · 1.7K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies

Richard Watts, Suzanne Lane, Thomas Hanslik et al. · Annals of the Rheumatic Diseases · 2006 · 1.4K citations · Full text

Life Sciences, Immunology, Clinical Classification Systems +11

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

Max Yates, Richard A. Watts, Ingeborg M. Bajema et al. · Annals of the Rheumatic Diseases · 2016 · 1.2K citations · Full text

Life Sciences, Clinical Sciences, Internal Medicine +16

EULAR recommendations for the management of primary small and medium vessel vasculitis

Chetan Mukhtyar, Loı̈c Guillevin, María C. Cid et al. · Annals of the Rheumatic Diseases · 2008 · 989 citations · Full text

Medicine, Internal Medicine, Nephrology +12

EULAR recommendations for the management of large vessel vasculitis

Chetan Mukhtyar, Loı̈c Guillevin, María C. Cid et al. · Annals of the Rheumatic Diseases · 2008 · 673 citations · Full text

Medicine, Internal Medicine, Nephrology +10